B.M.P. PHARMA TRAD (BMP.SG) (BMP) - Net Assets
Based on the latest financial reports, B.M.P. PHARMA TRAD (BMP.SG) (BMP) has net assets worth €8.90 Million EUR (≈ $10.40 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€12.67 Million ≈ $14.81 Million USD) and total liabilities (€3.77 Million ≈ $4.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BMP tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €8.90 Million |
| % of Total Assets | 70.23% |
| Annual Growth Rate | 5.42% |
| 5-Year Change | 3.31% |
| 10-Year Change | 73.03% |
| Growth Volatility | 12.88 |
B.M.P. PHARMA TRAD (BMP.SG) - Net Assets Trend (2013–2025)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s net assets have evolved over time, based on quarterly financial data. See B.M.P. PHARMA TRAD (BMP.SG) defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for B.M.P. PHARMA TRAD (BMP.SG) (2013–2025)
The table below shows the annual net assets of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2025. For live valuation and market cap data, see B.M.P. PHARMA TRAD (BMP.SG) (BMP) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €8.90 Million ≈ $10.40 Million |
-0.44% |
| 2024-12-31 | €8.94 Million ≈ $10.45 Million |
+2.93% |
| 2023-12-31 | €8.68 Million ≈ $10.15 Million |
-14.73% |
| 2022-12-31 | €10.18 Million ≈ $11.90 Million |
+18.23% |
| 2021-12-31 | €8.61 Million ≈ $10.07 Million |
+41.23% |
| 2020-12-31 | €6.10 Million ≈ $7.13 Million |
+2.86% |
| 2019-12-31 | €5.93 Million ≈ $6.93 Million |
+5.51% |
| 2018-12-31 | €5.62 Million ≈ $6.57 Million |
+8.92% |
| 2017-12-31 | €5.16 Million ≈ $6.03 Million |
+0.32% |
| 2016-12-31 | €5.14 Million ≈ $6.01 Million |
-0.11% |
| 2015-12-31 | €5.15 Million ≈ $6.02 Million |
+8.08% |
| 2014-12-31 | €4.76 Million ≈ $5.57 Million |
+0.87% |
| 2013-12-31 | €4.72 Million ≈ $5.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to B.M.P. PHARMA TRAD (BMP.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 402706139.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.05 Million | 34.23% |
| Other Components | €5.85 Million | 65.77% |
| Total Equity | €8.90 Million | 100.00% |
B.M.P. PHARMA TRAD (BMP.SG) Competitors by Market Cap
The table below lists competitors of B.M.P. PHARMA TRAD (BMP.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Good Way Technology Co Ltd
TWO:3272
|
$31.52 Million |
|
INSPIREMD 1/18 DL-0001
F:II2
|
$31.52 Million |
|
Xiabuxiabu Catering Management (China) Holdings Co. Ltd
F:0XI
|
$31.53 Million |
|
Reino Capital SA
WAR:RNC
|
$31.53 Million |
|
Banimmo SA
BR:BANI
|
$31.50 Million |
|
Vext Science Inc
F:VV5
|
$31.50 Million |
|
Scandium International Mining Corp
F:0E6
|
$31.49 Million |
|
Valartis Group AG
SW:VLRT
|
$31.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in B.M.P. PHARMA TRAD (BMP.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,935,863 to 8,896,160, a change of -39,703 (-0.4%).
- Net income of 2,480,297 contributed positively to equity growth.
- Other factors decreased equity by 2,520,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.48 Million | +27.88% |
| Other Changes | €-2.52 Million | -28.33% |
| Total Change | €- | -0.44% |
Book Value vs Market Value Analysis
This analysis compares B.M.P. PHARMA TRAD (BMP.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.07x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 5.29x to 3.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.98 | €5.20 | x |
| 2018-12-31 | €1.07 | €5.20 | x |
| 2019-12-31 | €1.13 | €5.20 | x |
| 2020-12-31 | €1.16 | €5.20 | x |
| 2021-12-31 | €1.64 | €5.20 | x |
| 2022-12-31 | €1.94 | €5.20 | x |
| 2023-12-31 | €1.65 | €5.20 | x |
| 2024-12-31 | €1.70 | €5.20 | x |
| 2025-12-31 | €1.69 | €5.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently B.M.P. PHARMA TRAD (BMP.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 27.88%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 107154.14%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.42x
- Recent ROE (27.88%) is above the historical average (13.01%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 6.80% | 10700.00% | 0.00x | 1.04x | €-151.10K |
| 2014 | 0.86% | 4100.00% | 0.00x | 1.03x | €-435.20K |
| 2015 | 7.48% | 3850.00% | 0.00x | 1.05x | €-129.70K |
| 2016 | -0.12% | -144.60% | 0.00x | 1.06x | €-520.21K |
| 2017 | 0.32% | 937.82% | 0.00x | 1.08x | €-499.37K |
| 2018 | 8.19% | 6404.23% | 0.00x | 1.07x | €-101.51K |
| 2019 | 5.22% | 27763.22% | 0.00x | 1.08x | €-283.39K |
| 2020 | 2.79% | 17000.00% | 0.00x | 1.14x | €-439.70K |
| 2021 | 30.41% | 58819.09% | 0.00x | 1.14x | €1.76 Million |
| 2022 | 15.42% | 95665.46% | 0.00x | 1.21x | €551.61K |
| 2023 | 31.71% | 4894360.07% | 0.00x | 1.40x | €1.88 Million |
| 2024 | 32.22% | 179439.64% | 0.00x | 1.50x | €1.99 Million |
| 2025 | 27.88% | 107154.14% | 0.00x | 1.42x | €1.59 Million |
Industry Comparison
This section compares B.M.P. PHARMA TRAD (BMP.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $104,098,884,852
- Average return on equity (ROE) among peers: -9.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| B.M.P. PHARMA TRAD (BMP.SG) (BMP) | €8.90 Million | 6.80% | 0.42x | $31.50 Million |
| AMUR MINERALS (A7L.SG) (A7L) | $1.48 Million | -41.15% | 0.23x | $25.62K |
| Novae Group Plc (NVAL) | $415.35 Billion | 9.36% | 0.89x | $42.56K |
| OPG POWER VENTURES (OPB.SG) (OPB) | $154.38 Million | 9.08% | 1.23x | $13.57 Million |
| SY PUBLIC UTIL -H- (SH3.SG) (SH3) | $889.93 Million | -15.64% | 0.33x | $353.87K |
About B.M.P. PHARMA TRAD (BMP.SG)
There is no Profile data available for BMP.SG.